TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36397060

Group type: EXPERIMENTAL
Intervention: Dosiomics model
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: DLR model
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Hybrid model
Number of subjects: 140
Study: 32043148

Group type: EXPERIMENTAL
Intervention: Supervised rehabilitation intervention (physical therapy and occupational therapy-based interventions)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Supervised rehabilitation intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual rehabilitation care
Number of subjects: 64
Study: 33421267

Group type: EXPERIMENTAL
Intervention: Inhaled and intravenous sodium nitrite
Number of subjects: 51
Study: 32410849

Group type: EXPERIMENTAL
Intervention: Pioglitazone Metformin complex (PM)
Number of subjects: 75
Study: 32965471

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 0
Study: 32132264

Group type: EXPERIMENTAL
Intervention: Anodal stimulation to the right temporoparietal junction (rTPJ)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Stimulation to the dorsomedial PFC
Number of subjects: 88
Study: 34697657

Group type: EXPERIMENTAL
Intervention: nano-silver (nano-Ag)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: nano-calcium hydroxide (nano-CH)
Number of subjects: 69

Group type: COMPARATOR
Intervention: calcium hydroxide (CH)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Cleaning and shaping (S1-S2)
Number of subjects: 69

Group type: COMPARATOR
Intervention: All groups (nano-Ag, nano-CH, CH)
Number of subjects: 69
Study: 32831070

Group type: EXPERIMENTAL
Intervention: Higher-risk groups (Group 0: 72.72%, Group 1: 5.9%, Group 2: 17.73%, Group 3: 3.63%)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Retinopathy
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Hyperkeratosis
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: School level
Number of subjects: 230
Study: 36316421

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (atDCS) applied to the left Dorsolateral Prefrontal Cortex (DLPFC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 31
Study: 33547702

Group type: EXPERIMENTAL
Intervention: Diabetes Patient‐Reported Outcome Measures (DiaPROM) pilot trial intervention
Number of subjects: 19

Group type: COMPARATOR
Intervention: Previous follow-up
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Completing questionnaires and discussing PAID scores
Number of subjects: 19
Study: 36104943

Group type: EXPERIMENTAL
Intervention: Endobiliary ablation combined with immune nutrition (IN)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (PTBD and standard early enteral nutrition)
Number of subjects: 59
Study: 34022376

Group type: EXPERIMENTAL
Intervention: Protocol-guided individualized nutritional support
Number of subjects: 506

Group type: COMPARATOR
Intervention: Standard hospital food
Number of subjects: 506
Study: 32248795

Group type: EXPERIMENTAL
Intervention: CORE (Cultivating Our Resilience), a 6-week training program to improve resilience
Number of subjects: 324

Group type: COMPARATOR
Intervention: HLP (Healthy Lifestyle Program), a 6-week training to promote a healthy lifestyle
Number of subjects: 324

Group type: COMPARATOR
Intervention: WL (Waiting List), waiting list control condition
Number of subjects: 324
Study: 32801009

Group type: EXPERIMENTAL
Intervention: Higher genetic allele score
Number of subjects: 117427

Group type: EXPERIMENTAL
Intervention: Highest vs lowest genetic allele score
Number of subjects: 117427

Group type: EXPERIMENTAL
Intervention: Higher unweighted allele scores
Number of subjects: 117427

Group type: EXPERIMENTAL
Intervention: Internally weighted higher allele scores
Number of subjects: 117427

Group type: EXPERIMENTAL
Intervention: Externally weighted higher allele scores
Number of subjects: 117427

Group type: EXPERIMENTAL
Intervention: Increase in triglycerides by 1 mmol/L (89 mg/dL)
Number of subjects: 117427
Study: 36422767

Group type: EXPERIMENTAL
Intervention: Virtual follow-up using asynchronous telemedicine system
Number of subjects: 28

Group type: COMPARATOR
Intervention: Face-to-face follow-up
Number of subjects: 28
Study: 33651740

Group type: EXPERIMENTAL
Intervention: Intimate Partner Violence (IPV) screening using the Woman Abuse Screening Tool (WAST)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Female Sexual Function Index (FSFI-6) total score
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: FSFI-6 domain scores (desire, arousal, lubrication, orgasm, satisfaction, pain)
Number of subjects: 187
Study: 32459348

Group type: EXPERIMENTAL
Intervention: e-coach-guided, web-based self-help intervention based on cognitive behavioral therapy
Number of subjects: 295

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 295
Study: 34726293

Group type: EXPERIMENTAL
Intervention: Ethosuximide 500 mg t.i.d along with mebeverine 135 mg t.i.d
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mebeverine 135 mg t.i.d
Number of subjects: 50
Study: 33041091

Group type: EXPERIMENTAL
Intervention: ω‐3 PUFA therapy (2 g daily for 3 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual therapy
Number of subjects: 60
Study: 35115003

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD) for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine diet for diabetes (Control) for 12 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine diet for diabetes (Control)
Number of subjects: 60
Study: 34352497

Group type: EXPERIMENTAL
Intervention: Attachment-based parenting intervention (Connect)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 140
Study: 36444835

Group type: EXPERIMENTAL
Intervention: Defaults group
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Online group
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study: 33646181

Group type: EXPERIMENTAL
Intervention: Semi-quantitative risk assessment method
Number of subjects: 10
Study: 32791681

Group type: EXPERIMENTAL
Intervention: Tonifying Kidney and Invigorating Brain acupuncture plus standardized physical rehabilitation treatment
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standardized physical rehabilitation treatment
Number of subjects: 72
Study: 32249509

Group type: EXPERIMENTAL
Intervention: Center-based group exercise program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Home-based individual exercise program
Number of subjects: 50
Study: 32305012

Group type: EXPERIMENTAL
Intervention: Combined Functional Training (CFT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 20
Study: 35766604

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07) for 90 days after surgery
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo supplementation for 90 days after surgery
Number of subjects: 101
Study: 32628678

Group type: EXPERIMENTAL
Intervention: Random Forest Lee Bounds (RFLB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Assuming MCAR or MAR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Missing outcome data considered as MNAR
Number of subjects: 0
Study: 34355784

Group type: EXPERIMENTAL
Intervention: Positive styloid process elongation
Number of subjects: 2010

Group type: EXPERIMENTAL
Intervention: Type I styloid process elongation
Number of subjects: 2010

Group type: EXPERIMENTAL
Intervention: Type II styloid process elongation
Number of subjects: 2010

Group type: EXPERIMENTAL
Intervention: Type III styloid process elongation
Number of subjects: 2010

Group type: EXPERIMENTAL
Intervention: Normal styloid process
Number of subjects: 2010

Group type: EXPERIMENTAL
Intervention: Normal styloid process in age group 18-24 years
Number of subjects: 2010

Group type: EXPERIMENTAL
Intervention: Type I pattern prevalence in age group 30-50 years
Number of subjects: 2010
Study: 32813051

Group type: EXPERIMENTAL
Intervention: COVID Impact Survey administered during the pandemic
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: HADS-depression scores at follow-up
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Perceived impact of the pandemic on psychological well-being
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 131
Study: 32803127

Group type: EXPERIMENTAL
Intervention: Behavioral design intervention package (health worker planning calendar, client counseling job aid, client appointment cards)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 34126291

Group type: EXPERIMENTAL
Intervention: Higher Cort:CRPmorn ratio levels at T1
Number of subjects: 122

Group type: COMPARATOR
Intervention: Lower Cort:CRPmorn ratio levels at T1
Number of subjects: 122
Study: 32152929

Group type: EXPERIMENTAL
Intervention: Attentional load during enumeration of canonical patterns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attentional load during enumeration of randomized arrangements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Centrally located canonical patterns
Number of subjects: 0
Study: 36476318

Group type: EXPERIMENTAL
Intervention: HCT Symptoms and Steps intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Education control
Number of subjects: 40
Study: 33454813

Group type: EXPERIMENTAL
Intervention: Regional cryoablation
Number of subjects: 23
Study: 32521620

Group type: EXPERIMENTAL
Intervention: Purchasing food in modern retailers
Number of subjects: 1429
Study: 35794564

Group type: EXPERIMENTAL
Intervention: Education intervention (8 sessions over 6 months)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 69
Study: 34544245

Group type: EXPERIMENTAL
Intervention: Clear sealants
Number of subjects: 6986

Group type: EXPERIMENTAL
Intervention: Opaque sealants
Number of subjects: 6986

Group type: EXPERIMENTAL
Intervention: Fissures
Number of subjects: 6986

Group type: EXPERIMENTAL
Intervention: Sealants on early carious lesions (ICDAS II 1‐3)
Number of subjects: 6986
Study: 32729141

Group type: EXPERIMENTAL
Intervention: Gyrus PKS™
Number of subjects: 64

Group type: COMPARATOR
Intervention: LigaSure™
Number of subjects: 64
Study: 34080498

Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) paracetamol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Modified-release (MR) paracetamol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Both IR and MR paracetamol
Number of subjects: 9
Study: 35482532

Group type: EXPERIMENTAL
Intervention: Avacopan 30 mg twice daily for 52 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Tapered prednisone over 20 weeks plus avacopan-matching placebo for 52 weeks
Number of subjects: 21
Study: 33165685

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation (HFS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Video-based learning (VBL)
Number of subjects: 0
Study: 35088397

Group type: EXPERIMENTAL
Intervention: HOT (35°C, 20.9% FiO2)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HH (35°C, 14.5% FiO2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: HYP (20°C, 14.5% FiO2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CON (20°C, 20.9% FiO2)
Number of subjects: 10
Study: 32203984

Group type: EXPERIMENTAL
Intervention: Pharmacologic or strategy-driven glucose-lowering interventions
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study: 33657443

Group type: EXPERIMENTAL
Intervention: Pegbelfermin (PGBF) 10, 20, or 40 mg subcutaneous injections once weekly for 48 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36087921

Group type: EXPERIMENTAL
Intervention: Virtual simulation-based training program for etonogestrel subdermal contraceptive implant insertion and removal
Number of subjects: 3162
Study: 32056721

Group type: EXPERIMENTAL
Intervention: Low-dose indacaterol acetate/mometasone furoate 150/80 μg once daily
Number of subjects: 802

Group type: COMPARATOR
Intervention: Mometasone furoate 200 μg once daily
Number of subjects: 802
Study: 34600129

Group type: EXPERIMENTAL
Intervention: Locoregional therapy plus adoptive transfer of allogeneic γδ T cells (HCC, Group B; ICC, Group D)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Locoregional therapy (HCC, Group A; ICC, Group C)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Locoregional therapy plus adoptive transfer of allogeneic γδ T cells (HCC, Group B)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Locoregional therapy (HCC, Group A)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Locoregional therapy plus adoptive transfer of allogeneic γδ T cells (ICC, Group D)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Locoregional therapy (ICC, Group C)
Number of subjects: 59
Study: 35662994

Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone
Number of subjects: 70
Study: 32945567

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy and therapeutic alliance feedback
Number of subjects: 0
Study: 36256926

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE, 0.625 mg/d)
Number of subjects: 9332

Group type: EXPERIMENTAL
Intervention: CEE + medroxyprogesterone acetate (MPA; 2.5 mg/d)
Number of subjects: 9332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9332
Study: 34429137

Group type: EXPERIMENTAL
Intervention: Balanced forced-diuresis using RenalGuard system (RG)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (current practice)
Number of subjects: 220
Study: 33079971

Group type: EXPERIMENTAL
Intervention: Model 1 (FLI plus GLUCOSE plus SEX plus AGE)
Number of subjects: 2970

Group type: EXPERIMENTAL
Intervention: Model 2 (AVI plus GLUCOSE plus GGT plus SEX plus AGE)
Number of subjects: 2970

Group type: EXPERIMENTAL
Intervention: Model 3 (BRI plus GLUCOSE plus GGT plus SEX plus AGE)
Number of subjects: 2970
Study: 35585558

Group type: EXPERIMENTAL
Intervention: Barbed suture wound closure
Number of subjects: 181

Group type: COMPARATOR
Intervention: Conventional suture closure
Number of subjects: 181
Study: 33644968

Group type: EXPERIMENTAL
Intervention: First-generation cephalosporins (group I, 150 patients)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Second-generation cephalosporins (group II, 150 patients)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Second-generation cephalosporins (group II)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: First-generation cephalosporins (group I)
Number of subjects: 300
Study: 32150060

Group type: EXPERIMENTAL
Intervention: Intercostal nerve block using a supraglottic device
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Paravertebral nerve block using a supraglottic device
Number of subjects: 120

Group type: COMPARATOR
Intervention: Double-lumen bronchial intubation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Comparison between group I and group P
Number of subjects: 120
Study: 36454738

Group type: EXPERIMENTAL
Intervention: Talazoparib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Talazoparib vs Standard therapy
Number of subjects: 0
Study: 33853099

Group type: EXPERIMENTAL
Intervention: Music therapy for 30 minutes
Number of subjects: 120

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 120
Study: 33565303

Group type: EXPERIMENTAL
Intervention: Educational programme and actual insulin injection demonstration (physician-led sample insulin injection using an insulin pen)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Educational programme
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 49
Study: 34493311

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) prophylaxis
Number of subjects: 54

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 54
Study: 32506857

Group type: EXPERIMENTAL
Intervention: Jinying capsules and oral levofloxacin plus oral metronidazole for first 7 days, followed by Jinying capsules with levofloxacin placebo and metronidazole placebo for another 7 days, and then Jinying capsules only for the remaining 14 days.
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group received oral levofloxacin and metronidazole with Jinying capsule placebo for the first 14 days, followed by Jinying capsule placebo only for the remaining 14 days.
Number of subjects: 155

Group type: COMPARATOR
Intervention: Jinying capsules (experimental group) vs. Jinying capsule placebo (control group) in TCM symptom pattern scores before and after treatment.
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Physicochemical indexes including white blood cell count, erythrocyte sedimentation rate, C-reactive protein, smear of vaginal discharge, and pelvic ultrasound.
Number of subjects: 155
Study: 33716034

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 136

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 136
Study: 32318603

Group type: EXPERIMENTAL
Intervention: Individual counseling during three sessions
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 90
Study: 36299540

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy with Adaptive Virtual Reality Exposure (CBT-ExpVR)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy with In Vivo Exposure (CBT-Exp)
Number of subjects: 90
Study: 33655943

Group type: EXPERIMENTAL
Intervention: Robot-assisted left-hand training (n=12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional treatments for neglect symptoms (n=12)
Number of subjects: 24
Study: 33079935

Group type: EXPERIMENTAL
Intervention: Nutrient bar supplementation (2 bars daily for 2 months)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no nutrient bar supplementation)
Number of subjects: 36
Study: 36424116

Group type: EXPERIMENTAL
Intervention: Patient-education booklet
Number of subjects: 24
Study: 34097854

Group type: EXPERIMENTAL
Intervention: Isatuximab plus carfilzomib-dexamethasone
Number of subjects: 302

Group type: COMPARATOR
Intervention: Carfilzomib-dexamethasone (Control)
Number of subjects: 302
Study: 32561260

Group type: EXPERIMENTAL
Intervention: 12-week skiing program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study: 34154896

Group type: EXPERIMENTAL
Intervention: Treadmill gait training in addition to standard burn rehabilitation (n=14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Overground gait training in addition to standard burn rehabilitation (n=14)
Number of subjects: 28
Study: 34052212

Group type: EXPERIMENTAL
Intervention: IV continuous diuretic therapy
Number of subjects: 5738

Group type: COMPARATOR
Intervention: IV intermittent bolus diuretic therapy
Number of subjects: 5738

Group type: COMPARATOR
Intervention: Oral diuretic therapy
Number of subjects: 5738
Study: 36286192

Group type: EXPERIMENTAL
Intervention: Oxygen saturation target of 90% to 94% (intervention; n = 216)
Number of subjects: 428

Group type: COMPARATOR
Intervention: Oxygen saturation target of 98% to 100% (standard care; n = 212)
Number of subjects: 428
Study: 33894156

Group type: EXPERIMENTAL
Intervention: iGBS meningitis
Number of subjects: 2258

Group type: EXPERIMENTAL
Intervention: Any iGBS disease
Number of subjects: 2258

Group type: EXPERIMENTAL
Intervention: iGBS disease
Number of subjects: 2258

Group type: COMPARATOR
Intervention: Household income
Number of subjects: 2258
Study: 32513138

Group type: EXPERIMENTAL
Intervention: HA‐WBRT+SIB
Number of subjects: 132

Group type: COMPARATOR
Intervention: WBRT+SIB
Number of subjects: 132
Study: 34518101

Group type: EXPERIMENTAL
Intervention: Epidural group (group E) with propofol, fentanyl, rocuronium, and epidural anesthesia with 0.25% levobupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Remifentanil group (group R) with remifentanil infusion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 34331840

Group type: EXPERIMENTAL
Intervention: Synthetic mesh
Number of subjects: 0

Group type: COMPARATOR
Intervention: No mesh
Number of subjects: 0

Group type: COMPARATOR
Intervention: Biologic mesh
Number of subjects: 0
Study: 32320490

Group type: EXPERIMENTAL
Intervention: Concomitant green tea ingestion with nadolol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Green tea ingestion 1 hour before nadolol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Water ingestion with nadolol (control)
Number of subjects: 11
Study: 35550819

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 105

Group type: COMPARATOR
Intervention: Conventional treatment (Warfarin and antiplatelets)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Dabigatran (in patients with MS)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Conventional treatment (in patients with MS)
Number of subjects: 105
Study: 34257570

Group type: EXPERIMENTAL
Intervention: Simultaneous Integrated Boost (SIB) delivered using RapidArc technique at doses of 2.4 Gy per fraction during pelvic irradiation with 50.4/1.8 Gy, total dose of 67.2 Gy for limited volume disease; parametric boost therapy added for advanced disease to a total dose of 79.2 Gy.
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Simultaneous cisplatin‐based chemotherapy for 5 cycles with a dosage of 40 mg/m2.
Number of subjects: 14
Study: 36225301

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (NH)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normobaric normoxia (NN)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hypobaric hypoxia (HH)
Number of subjects: 20
Study: 32385765

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided hydrodilatation via anterior rotator interval approach
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ultrasound-guided hydrodilatation via posterior intra-articular approach
Number of subjects: 60
Study: 34939248

Group type: EXPERIMENTAL
Intervention: Workshop and home visit group (n=30)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Home visit only group (n=31)
Number of subjects: 61
Study: 33202482

Group type: COMPARATOR
Intervention: Mechanically assisted walking training without body weight support
Number of subjects: 451

Group type: COMPARATOR
Intervention: Mechanically assisted walking training with body weight support
Number of subjects: 451
Study: 33506796

Group type: EXPERIMENTAL
Intervention: Interdisciplinary position statements on PFO management in various clinical settings, based on limited and observational or low-certainty randomized data.
Number of subjects: 0